COVID-19ワクチン接種後の肝障害

基本情報

NCT ID: NCT05470894
ステータス: 完了
試験のフェーズ: -
試験タイプ: 観察
目標被験者数: 379
治験依頼者名: Humanity & Health Medical Group Limited

概要

The COVID-19 pandemic, caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), is still raging across the world and vaccination is expected to lead us out of this pandemic. Although the efficacy of these vaccines is beyond doubt, safety still remains a concern. Liver injury, such as autoimmune hepatitis (AIH), has been reported after COVID-19 vaccination. The aim of this prospective study is to investigate the spectrum and profile of liver injury after COVID-19 vaccination in Asia-Pacific region and to explore the potential risk factors for the development of liver injury.

対象疾患

Subjects After COVID-19 Vaccination

介入

Approved COVID-19 vaccine(BIOLOGICAL)

依頼者（Sponsor）

Nihon University School Of Medicine(UNKNOWN)

Tokyo University(OTHER)

Humanity & Health Medical Group Limited(OTHER)

実施施設 (2)

Tokyo University

Tokyo, Japan

日本大学医学部徳沢診療所

Tokyo, Japan